Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: Differences in primary structural requirements for RANTES, MIP-1α, and vMIP-II binding

Journal of Molecular Biology

Volumn 313, Issue 5, 2001, Pages 1181-1193

  Navenot, Jean Marc ^a   Wang, Zi Xuan ^a   Trent, John O ^a   Murray, James L ^a   Hu, Qin Xue ^a   DeLeeuw, Lynn ^a   Moore, Patrick S ^b   Chang, Yuan ^b   Peiper, Stephen C ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

CCR5; Chemokines; HIV 1 coreceptor; Ligand binding; vMIP II

Indexed keywords

CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROTEIN VMIP 2; RANTES; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

HERPESVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035834496     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.5086     Document Type: Article

References (35)

1. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
2. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
3. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
4. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
5. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophagetropic HIV-1
6. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co- receptor CCR-5
7. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
8. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
9. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
10. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
11. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
12. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
13. Identification of a major co-receptor for primary isolates of HIV-1
14. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
15. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
16. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
17. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
18. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
19. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
20. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein
21. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry
22. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
23. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120
24. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry
25. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization
26. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1
27. CCR5 HIV-1 coreceptor activity. Role of cooperativity between residues in N-terminal extracellular and intracellular domains
28. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV- suppressive factors produced by CD8+ T cells
29. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates
30. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV
31. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
32. The second extracellular loop of CCR5 is the major determinant of ligand specificity
33. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
34. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins
35. CCR5 HIV-1 coreceptor activity. Role of cooperativity between residues in N-terminal extracellular and intracellular domains